Linde (NYSE: LIN) COO Sean Durbin receives stock awards and options

Rhea-AI Filing Summary

Linde plc EVP and COO Sean Durbin reported multiple equity compensation events. Performance share units and restricted stock units granted in March 2023 vested on March 9, 2026, converting one-for-one into Linde ordinary shares. The company withheld 3,602 ordinary shares at $484.74 per share to cover tax obligations, which are not open-market sales.

Durbin also received new grants of 2,857 restricted stock units and 23,290 stock options with a $483.62 exercise price, vesting over three years beginning March 9, 2027. Following these transactions, he directly holds 12,264.559 ordinary shares and retains sizeable unexercised options and deferred/restricted stock units expiring between 2030 and 2035.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Durbin Sean

(Last) (First) (Middle)

C/O LINDE PLC

FORGE, 43 CHURCH STREET WEST

(Street)

WOKING SURREY X0 GU216HT

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
LINDE PLC [ LIN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Chief Operating Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/09/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	03/09/2026		M		4,526(1)	A	$0	12,676.559	D
Ordinary Shares	03/09/2026		F		2,112(2)	D	$484.74	10,564.559	D
Ordinary Shares	03/09/2026		M		1,595(1)	A	$0	12,159.559	D
Ordinary Shares	03/09/2026		F		745(2)	D	$484.74	11,414.559	D
Ordinary Shares	03/09/2026		M		1,595(3)	A	$0	13,009.559	D
Ordinary Shares	03/09/2026		F		745(2)	D	$484.74	12,264.559	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Performance Share Units (ROC)	$0	03/09/2026		A		4,526		(4)	(4)	Ordinary Shares	4,526	$0	4,526	D
Performance Share Units (ROC)	$0	03/09/2026		M			4,526	(4)	(4)	Ordinary Shares	4,526	$0	0	D
Performance Share Units (RTSR)	$0	03/09/2026		A		1,595		(5)	(5)	Ordinary Shares	1,595	$0	1,595	D
Performance Share Units (RTSR)	$0	03/09/2026		M			1,595	(5)	(5)	Ordinary Shares	1,595	$0	0	D
Restricted Stock Units	(6)	03/09/2026		A		2,857		(7)	(7)	Ordinary Shares	2,857	$0	2,857	D
Restricted Stock Units	(6)	03/09/2026		M			1,595	(8)	(8)	Ordinary Shares	1,595	$0	0	D
Restricted Stock Units	$0							(9)	(9)	Ordinary Shares	1,551		1,551	D
Restricted Stock Units	(6)							(10)	(10)	Ordinary Shares	1,470		1,470	D
Stock Options (right to buy)	$483.62	03/09/2026		A		23,290		(11)	03/09/2036	Ordinary Shares	23,290	$0	23,290	D
Stock Options (right to buy)	$468.77							(12)	03/07/2035	Ordinary Shares	10,889		10,889	D
Stock Options (right to buy)	$465.29							(13)	03/07/2034	Ordinary Shares	9,610		9,610	D
Stock Options (right to buy)	$354.14							(14)	03/07/2033	Ordinary Shares	10,540		10,540	D
Stock Options (right to buy)	$253.68							(15)	03/08/2031	Ordinary Shares	19,070		19,070	D
Stock Options (right to buy)	$173.13							(16)	03/09/2030	Ordinary Shares	7,045		7,045	D
Deferred Stock Units	(6)							(17)	(17)	Ordinary Shares	391.203		391.203	D

Explanation of Responses:

1. Ordinary shares acquired pursuant to the payout of a performance share unit ("PSU") grant made on March 7, 2023.

2. Ordinary shares withheld from the payout to cover tax withholdings.

3. Ordinary shares acquired pursuant to the payout of a restricted stock unit ("RSU") grant made on March 7, 2023.

4. The PSU paid out on March 9, 2026, and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Linde plc from 2023-2025 measured against ROC goals set by the Human Capital Committee of the Board of Directors when the PSU was granted on March 7, 2023.

5. The PSU paid out on March 9, 2026, and the number of shares awarded and paid out was determined based upon the relative total shareholder return ("RTSR") of Linde plc from 2023-2025 measured against TSR goals set by the Human Capital Committee of the Board of Directors when the PSU was granted on March 7, 2023.

6. Conversion to Linde plc Ordinary Shares is on a one-for-one basis.

7. Restricted Stock Units that will vest in full and payout on or about March 9, 2029 in Linde plc Ordinary Shares on a one-for-one basis.

8. Restricted Stock Units that vested in full and paid out on March 9, 2026 in Linde plc Ordinary Shares on a one-for-one basis.

9. Restricted Stock Units that will vest in full and payout on or about March 7, 2028 in Linde plc Ordinary Shares on a one-for-one basis.

10. Restricted Stock Units that will vest in full and payout on or about March 7, 2027 in Linde plc Ordinary Shares on a one-for-one basis.

11. This option vests over three years in three consecutive equal annual installments beginning on March 9, 2027.

12. This option vests over three years in three consecutive equal annual installments beginning on March 7, 2026.

13. This option vests over three years in three consecutive equal annual installments beginning on March 7, 2025.

14. This option vests over three years in three consecutive equal annual installments beginning on March 7, 2024.

15. This option vests over three years in three consecutive equal annual installments beginning on March 8, 2022.

16. This option vests over three years in three consecutive equal annual installments beginning on March 9, 2021.

17. Deferred stock units acquired under the Linde Compensation Deferral Plan as amended ("Plan"). The deferred stock units will payout in Linde plc Ordinary Shares on a one-for-one basis in accordance with the Plan.

Remarks:

	Anthony M. Pepper as attorney-in-fact	03/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Linde (LIN) EVP Sean Durbin report in this Form 4 filing?

Sean Durbin reported equity compensation activity, including vesting of prior performance and restricted stock units into ordinary shares and new grants of restricted stock units and stock options. The events reflect scheduled payouts and awards under Linde’s long-term incentive programs.

How many Linde ordinary shares does Sean Durbin hold after these transactions?

After these transactions, Sean Durbin directly holds 12,264.559 Linde ordinary shares. This balance reflects shares received from vested performance and restricted units, net of shares withheld by the company to cover associated tax obligations at the time of payout.

Were any of Sean Durbin’s Linde share dispositions open-market sales?

No, the dispositions reported used code F, indicating shares were withheld to cover exercise price or tax liabilities. These 3,602 shares were retained by the company for tax withholding and do not represent open-market sales or discretionary selling activity by Durbin.

What new equity awards did Sean Durbin receive from Linde in this filing?

Durbin received 2,857 restricted stock units and 23,290 stock options with a $483.62 exercise price. The options vest in three equal annual installments beginning March 9, 2027, providing long-dated equity exposure aligned with Linde’s future performance.

How were Linde’s performance share units (ROC and RTSR) determined for Sean Durbin?

The performance share units paid out on March 9, 2026, with shares determined by Linde’s average annual return on capital from 2023–2025 and relative total shareholder return over the same period versus goals set by the Board’s Human Capital Committee when granted.

What ongoing derivative equity positions does Sean Durbin retain in Linde shares?

Durbin retains multiple unexercised stock option grants over Linde ordinary shares, with exercise prices such as $468.77, $465.29, $354.14 and $253.68, expiring between 2030 and 2035, plus outstanding restricted and deferred stock units convertible one-for-one into shares.